About
BellaSeno is a clinical-stage medtech company based in Leipzig, Germany, with a subsidiary in Brisbane, Australia. Founded in 2015, the company specializes in developing innovative, fully resorbable soft tissue and bone reconstruction implants using advanced 3D printing technologies. BellaSeno's proprietary platform creates resorbable scaffolds from well-characterized polymers, designed to support natural tissue growth while being gradually absorbed by the body. The company is advancing several products, including resorbable breast implants for reconstruction and augmentation, custom-made pectus scaffolds for chest wall defects, and bone defect scaffolds for complex bone issues. BellaSeno has successfully completed clinical trials for its breast implants, demonstrating favorable safety and quality-of-life outcomes. The company aims to expand its clinical applications and collaborates with leading medtech players and healthcare providers in plastic surgery and orthopedics. BellaSeno is supported by substantial funding from various public and private sources, enhancing its development and regulatory strategies.
Technologies
Keywords
Company Information
-
Employees 22
-
Founded 2015
-
Total Funding $1121760
Location
5A Deutscher Platz, Leipzig, Saxony, Germany, 04103